Therapeutic value of interleukin-3 given alone or in combination with other cytokines

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.

Bone marrow transplantation·2023

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

Scientific reports·2023

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.

Bone marrow transplantation·2019

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Leukemia·2019

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO).

Annals of hematology·2017

Allogeneic transplantation of peripheral blood progenitor cells.

Nouvelle revue francaise d'hematologie·1995

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Nouvelle revue francaise d'hematologie·1995

Peripheral blood CD34+ cells: method of purification and ex vivo expansion.

Nouvelle revue francaise d'hematologie·1995

Ex vivo expansion of human peripheral blood progenitors.

Nouvelle revue francaise d'hematologie·1995

Expansion of blood CD34 positive cells: committed precursors expansion does not affect immature hematopoietic progenitors.

Nouvelle revue francaise d'hematologie·1995

In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients.

Nouvelle revue francaise d'hematologie·1995

Large-Bore Aspiration Thrombectomy for Recurrent Iliofemoral DVT in Congenital IVC Interruption With Azygous Continuation.

JACC. Case reports·2026

Healthy bone marrow transplantation into hypertriglyceridemic rats improves cardiac reparative fibrosis post-myocardial infarction.

Cardiovascular research·2026

Exploring antibody-antigen binding affinity using degree-based topological indices: a graph-theoretical approach.

Frontiers in chemistry·2026

Relapsed/refractory multiple myeloma with extramedullary plasmacytomas successfully rechallenged with humanized B-cell maturation antigen-directed chimeric antigen receptor T-cell immunotherapy in an advanced disease stage: A case report.

Experimental and therapeutic medicine·2026

Soluble CTLA-4 as a context-dependent immune checkpoint: biology, biomarker potential, and therapeutic implications.

Frontiers in immunology·2026

Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A.

Blood vessels, thrombosis & hemostasis·2026

Related Experiment Videos

Therapeutic value of interleukin-3 given alone or in combination with other cytokines

Related Concept Videos

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO).

Allogeneic transplantation of peripheral blood progenitor cells.

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Peripheral blood CD34+ cells: method of purification and ex vivo expansion.

Ex vivo expansion of human peripheral blood progenitors.

Expansion of blood CD34 positive cells: committed precursors expansion does not affect immature hematopoietic progenitors.

In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients.

Large-Bore Aspiration Thrombectomy for Recurrent Iliofemoral DVT in Congenital IVC Interruption With Azygous Continuation.

Healthy bone marrow transplantation into hypertriglyceridemic rats improves cardiac reparative fibrosis post-myocardial infarction.

Exploring antibody-antigen binding affinity using degree-based topological indices: a graph-theoretical approach.

Relapsed/refractory multiple myeloma with extramedullary plasmacytomas successfully rechallenged with humanized B-cell maturation antigen-directed chimeric antigen receptor T-cell immunotherapy in an advanced disease stage: A case report.

Soluble CTLA-4 as a context-dependent immune checkpoint: biology, biomarker potential, and therapeutic implications.

Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A.

Related Experiment Videos

Therapeutic value of interleukin-3 given alone or in combination with other cytokines

Related Concept Videos

Related Articles